Guardant Health Inc (NASDAQ:GH) price on Thursday, January 16, fall -0.51% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $37.31.
A look at the stock’s price movement, the close in the last trading session was $37.50, moving within a range at $36.86 and $37.87. The beta value (5-Year monthly) was 1.106. Turning to its 52-week performance, $39.29 and $15.81 were the 52-week high and 52-week low respectively. Overall, GH moved 7.34% over the past month.
Guardant Health Inc’s market cap currently stands at around $4.61 billion, with investors looking forward to this quarter’s earnings report slated for in February.
Analysts have a consensus estimate of 188.63M for the company’s revenue for the quarter, with a low and high estimate of 186.5M and 200M respectively. The average forecast suggests up to a 21.66% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 725.7M, representing a 28.68% jump on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that GH is a 100% Buy. On the other hand, the stock is on average a 100% Buy as suggested by medium term indicators while long term indicators are putting the stock in 100% Buy category.
13 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 13 recommend GH as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
GH’s current price about 10.26% and 13.26% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 65.55, while 7-day volatility ratio is 6.38% and 5.43% in the 30-day chart. Further, Guardant Health Inc (GH) has a beta value of 1.28, and an average true range (ATR) of 1.85. Analysts have given the company’s stock an average 52-week price target of $40, forecast between a low of $37 and high of $50. Looking at the price targets, the low is 0.83% off current price level while to achieve the yearly target high, price needs to move -34.01%. Nonetheless, investors will most likely welcome a -7.21% jump to $40 which is the analysts’ median price.
If we refocus on Guardant Health Inc (NASDAQ:GH), historical trading data shows that trading volumes averaged 2.25 over the past 10 days and 1.88 million over the past 3 months. The company’s latest data on shares outstanding shows there are 123.16 million shares.
The 4.71% of Guardant Health Inc’s shares are in the hands of company insiders while institutional holders own 103.04% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 7.79 million on 2024-12-31, giving us a short ratio of 5.27. The data shows that as of 2024-12-31 short interest in Guardant Health Inc (GH) stood at 656.9999999999999 of shares outstanding, with shares short falling to 9.17 million registered in 2024-11-29. Current price change has pushed the stock 22.13% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the GH stock continues to rise going into the next quarter.
